Clinical Trials Browser

Unknown × Pathologic Complete Response × Trastuzumab × Clear all

NCT02059876 2014-02-12

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

Phase 2 Unknown

Pathologic Complete Response, Breast Neoplasms